Arthrosi Therapeutics
Developer of biotechnology drugs designed to reduce flare and tophi in gout patients. The company provides clinical-stage research and development services focused on therapy for gout and chronic kidn...
Valuation
$950M
Market implied
Share Price
N/A
Total Raised
$298.8M
Last Round
N/A